| |
 |
|
Class Information
Number: 514/312
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Bicyclo ring system having the six-membered hetero ring as one of the cyclos > Quinolines (including hydrogenated) > Chalcogen attached directly to the six-membered hetero ring by nonionic bonding
Description: Subject matter wherein chalcogen (i.e., oxygen, sulfur, selenium or tellurium) is attached directly to the six-membered hetero ring of the quinoline ring system by nonionic bonding.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7612115 |
Aqueous pharmaceutical compositions |
Nov. 3, 2009 |
| 7612092 |
Nitrogen-containing aromatic derivatives |
Nov. 3, 2009 |
| 7598268 |
Quinolinone derivatives |
Oct. 6, 2009 |
| 7598258 |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor |
Oct. 6, 2009 |
| 7595328 |
Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria |
Sep. 29, 2009 |
| 7585845 |
Hepatitis C inhibitor compounds |
Sep. 8, 2009 |
| 7579363 |
Bicyclic compounds and compositions as PDF inhibitors |
Aug. 25, 2009 |
| 7576100 |
Muscarinic agonists |
Aug. 18, 2009 |
| 7563806 |
Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament |
Jul. 21, 2009 |
| 7563805 |
Tri-, tetra-substituted-3-aminopyrrolidine derivative |
Jul. 21, 2009 |
| 7563804 |
FMF treatment |
Jul. 21, 2009 |
| 7563460 |
Enteric coated oral pharmaceutical to erode kidney stones |
Jul. 21, 2009 |
| 7560483 |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
Jul. 14, 2009 |
| 7553855 |
Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide |
Jun. 30, 2009 |
| 7553854 |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
Jun. 30, 2009 |
| 7550453 |
2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
Jun. 23, 2009 |
| 7534802 |
Compounds having 4-pyridylalkylthio group as substituent |
May. 19, 2009 |
| 7534793 |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
May. 19, 2009 |
| 7531553 |
Heterocyclic compounds and methods of use |
May. 12, 2009 |
| 7514451 |
7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative |
Apr. 7, 2009 |
| 7511062 |
Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
Mar. 31, 2009 |
| 7507749 |
Antitumor agents |
Mar. 24, 2009 |
| 7504416 |
4-substituted quinolines as antitumor agents |
Mar. 17, 2009 |
| 7504378 |
Macrocyclic peptides active against the hepatitis C virus |
Mar. 17, 2009 |
| 7498343 |
Mycobacterial inhibitors |
Mar. 3, 2009 |
| 7488739 |
Quinolone derivative or salt thereof |
Feb. 10, 2009 |
| 7488725 |
Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods |
Feb. 10, 2009 |
| 7488494 |
Compositions and therapeutic methods involving isoflavones and analogues thereof |
Feb. 10, 2009 |
| 7482341 |
Pyridines |
Jan. 27, 2009 |
| 7476675 |
Quinolinone derivatives and uses thereof |
Jan. 13, 2009 |
| 7476673 |
Disubstituted chalcone oximes as selective agonists of RAR.sub..gamma. retinoid receptors |
Jan. 13, 2009 |
| 7470709 |
Benzimidazole quinolinones and uses thereof |
Dec. 30, 2008 |
| 7470708 |
Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
Dec. 30, 2008 |
| 7468378 |
Substituted quinoline compounds |
Dec. 23, 2008 |
| 7456196 |
Bicyclic-substituted amines as histamine-3 receptor ligands |
Nov. 25, 2008 |
| 7455840 |
Compositions and methods to reduce mutagenesis |
Nov. 25, 2008 |
| 7452874 |
Thrombopoietin mimetics |
Nov. 18, 2008 |
| 7449479 |
Hepatitis C virus inhibitors |
Nov. 11, 2008 |
| 7449478 |
Indole compounds |
Nov. 11, 2008 |
| 7442710 |
Substituted phenyl methanones |
Oct. 28, 2008 |
| 7442695 |
Depeptidized inhibitors of hepatitis C virus NS3 protease |
Oct. 28, 2008 |
| 7431916 |
Administration of medicinal dry powders |
Oct. 7, 2008 |
| 7429583 |
Betamimetics for the treatment of respiratory complaints |
Sep. 30, 2008 |
| RE40525 |
Hepatitis C inhibitor tri-peptides |
Sep. 30, 2008 |
| 7425564 |
Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
Sep. 16, 2008 |
| 7423036 |
Long-acting betamimetics for the treatment of respiratory complaints |
Sep. 9, 2008 |
| 7402598 |
Arylethanolamine .beta..sub.2-adrenoreceptor agonist compounds |
Jul. 22, 2008 |
| 7402583 |
Substituted quinolines as antitumor agents |
Jul. 22, 2008 |
| 7396839 |
Crystalline forms of gatifloxacin |
Jul. 8, 2008 |
| RE40418 |
Treatment of neoplasms with CCI-779/EKB-569 combination |
Jul. 1, 2008 |
|
|
|
